Balancing risks and therapeutic benefits. About adjuvant tamoxifen treatment for breast cancer patients

被引：7
|
作者：
Sarradon-Eck, Aline [1 ]
Pellegrini, Isabelle [2 ]
机构：
[1] MMSH, Ctr Norbert Elias, Equipe GReCSS PAS Anthropol Sante, F-130949 Aix En Provence, France
[2] Inst Paoli Calmette, INSERM, UMR SE4S 912, F-13273 Marseille 09, France
来源：
SCIENCES SOCIALES ET SANTE | 2012年 / 30卷 / 01期
关键词：
TREATMENT DECISION-MAKING; MEDICAL UNCERTAINTY; WOMENS PERCEPTIONS; CHEMOTHERAPY; HEALTH; EXPERIENCE;
D O I：
10.3917/sss.301.0047
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
One of the main tools available for making bio-medical decisions about the best treatment to prescribe is the risk-benefit ratio. This article takes a contextual approach to the decision-making processes involved in the prescription of adjuvant tamoxifen as a mean of reducing the risk of relapse of breast cancer. Using anthropological descriptive methods, it examines the discrepancy between patients' and doctors' perceptions of the risks and benefits of the treatment and analyses their underlying logics. Representations of women are related to cancer (fear of the disease), its treatment (efficacy) and tamoxifen (fear of hormones and aging), and can lead to a symbolic hierarchy of treatments, whereas doctors' professional practices focus mainly on the prevention of the recurrence of cancers.
引用
收藏
页码：47 / 71
页数：25
相关论文
共 50 条
  • [1] Quality of life and adjuvant tamoxifen treatment in breast cancer patients
    Boehm, D. U.
    Lebrecht, A.
    Eckhardt, T.
    Albrich, S.
    Schmidt, M.
    Siggelkow, W.
    Kandelhardt, E.
    Koelbl, H.
    EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (05) : 500 - 506
  • [2] Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives
    Oliveri, Serena
    Lanzoni, Lucilla
    Veldwijk, Jorien
    de Wit, G. Ardine
    Petrocchi, Serena
    Janssens, Rosanne
    Schoefs, Elise
    Smith, Meredith Y.
    Smith, Ian
    Nackaerts, Kristiaan
    Vandevelde, Marie
    Louis, Evelyne
    Decaluwe, Herbert
    De Leyn, Paul
    Declerck, Hanne
    Petrella, Francesco
    Casiraghi, Monica
    Galli, Giulia
    Garassino, Marina Chiara
    Girvalaki, Charis
    Huys, Isabelle
    Pravettoni, Gabriella
    FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [3] Adjuvant treatment delay in breast cancer patients
    Trufelli, Damila Cristina
    de Matos, Leandro Luongo
    Santi, Patricia Xavier
    Del Giglio, Auro
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2015, 61 (05): : 411 - 416
  • [4] Patients' Perspective about Risks and Benefits of Treatment for Peripheral Arterial Disease
    Zafar, Abdul M.
    Harris, Tyler J.
    Murphy, Timothy P.
    Machan, Jason T.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 22 (12) : 1657 - 1661
  • [5] THE EFFECT OF ADJUVANT THERAPY WITH OR WITHOUT TAMOXIFEN ON THE ENDOCRINE FUNCTION OF PATIENTS WITH BREAST-CANCER
    YASUMURA, T
    AKAMI, T
    MITSUO, M
    OKA, T
    NAITOH, K
    YAMAMOTO, T
    HONJYO, H
    OKADA, H
    JAPANESE JOURNAL OF SURGERY, 1990, 20 (04): : 369 - 375
  • [6] Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer:: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group
    Morales, Leilani
    Canney, Peter
    Dyczka, Jaroslaw
    Rutgers, Emiel
    Coleman, Robert
    Cufer, Tanja
    Welnicka-Jaskiewicz, Marzena
    Nortier, Johan
    Bogaerts, Jan
    Therasse, Patrick
    Paridaens, Robert
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 331 - 340
  • [7] Prediction of Benefit From Adjuvant Treatment in Patients With Breast Cancer
    Eng-Wong, Jennifer
    Isaacs, Claudine
    CLINICAL BREAST CANCER, 2010, 10 : E32 - E37
  • [8] Fatigue in Breast Cancer Patients on Adjuvant Treatment: Course and Prevalence
    Manir, Kazi S.
    Bhadra, Kallol
    Kumar, Gaurav
    Manna, Amitabha
    Patra, Niladri B.
    Sarkar, Shyamal K.
    INDIAN JOURNAL OF PALLIATIVE CARE, 2012, 18 (02) : 109 - 116
  • [9] The tamoxifen paradoxinfluence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer
    Kyvernitakis, I.
    Kostev, K.
    Hadji, P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (11) : 2557 - 2564
  • [10] Knowledge About Risks, Benefits, and Curative Potential of Immunotherapy Among Patients with Advanced Cancer
    Petrillo, Laura A.
    Zhou, Ashley Z.
    Sullivan, Ryan
    Volandes, Angelo
    Greer, Joseph A.
    Temel, Jennifer S.
    El-Jawahri, Areej
    ONCOLOGIST, 2021, 26 (11): : E2090 - E2093
12345